This is not the most recent version of the article. View current version (16 MAR 2011)

Intervention Protocol

Antioxidant supplements for liver diseases

  1. Goran Bjelakovic1,*,
  2. Dimitrinka Nikolova1,
  3. Lise Lotte Gluud1,
  4. Marija Bjelakovic2,
  5. Aleksandar Nagorni3,
  6. Christian Gluud1

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD007749


How to Cite

Bjelakovic G, Nikolova D, Gluud LL, Bjelakovic M, Nagorni A, Gluud C. Antioxidant supplements for liver diseases (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007749. DOI: 10.1002/14651858.CD007749.

Author Information

  1. 1

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  2. 2

    Medical Faculty, University of Nis, Institute of Anatomy, Nis, Serbia

  3. 3

    Medical Faculty, University of Nis, Department of Internal Medicine - Gastroenterology and Hepatology, Nis, Serbia

*Goran Bjelakovic, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. goranb@junis.ni.ac.yu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (16 MAR 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of the antioxidant supplements beta-carotene, vitamin A, vitamin C, vitamin E, and selenium for treatment of acute and chronic liver disease, apart from non-alcoholic fatty liver disease, which is dealt with in another Cochrane Hepato-Biliary Group Review (Lirussi 2007).